CD4 and hepatocellular carcinoma: Therefore, the reduced number of CD3+, CD4+, CD19+ T cells in patients with HCC to some extent indicates a decline in the body's antiviral ability, which ultimately contributes to the deterioration of diseases caused by persistent virus infection.